Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Panacea Life Sciences Holdings, Inc. (PLSH : OTC)

• Company Description    Panacea Life Sciences is involved in production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets. The company produces soft gels, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online and in stores as well as in smart kiosk vending machines. Panacea Life Sciences, formerly known as Exactus Inc., is based in DELRAY BEACH, FL. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.10 Daily Weekly Monthly 20 Day Moving Average: 3,363 shares Shares Outstanding: 68.04 (millions) Market Capitalization: $6.80 (millions) Beta: 2.54 52 Week High: $0.14 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -0.49% 12 Week 198.51% 184.89% Year To Date 100.00% 76.71%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5910 S University Blvd C18-193 - Greenwood Village,CO 80121 USA ph: 800-985-0515 fax: - None http://www.panacealife.com

• General Corporate Information    Officers Leslie Buttorff - Chief Executive Officer; Chairman and Chief Financ Nick Cavarra - President Nathan Berman - Controller Lawrence J. Wert - Director James Baumgartner - Chief Science Officer and Quality Control Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 69810P109 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 68.04 Most Recent Split Date: 10.00 (0.04:1) Beta: 2.54 Market Capitalization: $6.80 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 25.67 EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -78.60% vs. Previous Quarter: -61.34% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - - Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - - Operating Margin 06/30/26 - -609.06 03/31/26 - 294.70 12/31/25 - 157.08 Net Margin 06/30/26 - -2,139.25 03/31/26 - -915.67 12/31/25 - -45.77 Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©